6.35 USD
↘ 0.01 (0.08%)AT CLOSE (03:59 PM EST)
Cartesian Therapeutics, Inc. Common Stock
RNACNASDAQ • USD
6.35
↗ 0.00 (0.00%)
POST MARKET (AS OF 07:59 PM EST)
Post Market
AS OF 07:59 PM EST
6.35
↗ 0.00 (0.00%)
Market: CLOSED
Cartesian Therapeutics, Inc. Common Stock (RNAC) trades at $6.35 per share. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (99.3%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation front, RNAC trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.
Technical & fundamental data as of Nov 13, 2026.
Open?$6.39
High?$6.40
Low?$6.16
Prev. Close?$6.36
Volume?106.8K
Avg. Volume?140.2K
VWAP?$6.28
Rel. Volume?0.76x
Bid / Ask
Bid?$6.20 × 4.0K
Ask?$6.50 × 100
Spread?$0.30
Midpoint?$6.35
Valuation & Ratios
Market Cap?193.7M
Shares Out?30.3M
Float?13.7M
Float %?45.4%
P/E Ratio?N/A
P/B Ratio?-1.48
EPS?-$4.25
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.
Themes
Employees
75
Market Cap
193.8M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2016-06-22
Address
7495 NEW HORIZON WAY
FREDERICK, MD 21703
Phone: 301-348-8698
FREDERICK, MD 21703
Phone: 301-348-8698
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?35
Short Sent.?48
Piotroski F-Score?0/9Weak
Altman Z-Score?-5.11Distress
Confidence?55%Low
Short InterestVery High
Short % of Float?13.96%High
Short Interest?1.9M
Days to Cover?16.5
Free Float13.7M
Avg Daily Volume116.2K
Settlement Date2026-10-30
Financial Health
Current Ratio?8.38Strong
Quick Ratio?8.38Strong
Cash Ratio?7.83Strong
Debt/Equity?-0.38Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?-1.48CHEAP▾
S&P97
P/S?188.97HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-1.2CHEAP▾
S&P97
EV/Sales?117.99HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?99.3%STRONG▾
Peers50
S&P97
ROA?-44.0%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-89893000
Enterprise Value?$120.9M
Fundamentals ratios updated end of day